Phathom Pharmaceuticals (PHAT) Balance Sheet: Assets & Liabilities

Phathom Pharmaceuticals (PHAT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Phathom Pharmaceuticals reported total assets of $259.15M and total liabilities of $697.32M. Shareholders' equity was negative at −$438.17M, meaning liabilities exceed assets. Total debt stood at $209.74M against $129.97M in cash and short-term investments, a net debt position of $79.76M.

Phathom Pharmaceuticals Balance Sheet Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Phathom Pharmaceuticals, Inc. (PHAT) - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	0.13	0.30	0.38	0.16	0.18	0.29	0.24	0.00
Cash & Short-Term Investments	0.13	0.30	0.38	0.16	0.18	0.29	0.24	0.00
Accounts Receivable	0.08	0.04	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.02	0.02	0.01	0.01	0.00	0.00	0.01	0.00
Total Current Assets	0.23	0.36	0.40	0.16	0.19	0.29	0.26	0.00
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.03	0.02	0.01	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.03	0.02	0.02	0.00	0.00	0.00	0.00	0.00
Total Assets	0.26	0.38	0.41	0.16	0.19	0.30	0.26	0.00
Current Liabilities
Accounts Payable	0.00	0.01	0.01	0.01	0.01	0.02	0.00	0.00
Short-Term Debt	0.00	0.02	0.01	0.00	0.00	0.01	0.00	0.00
Current Portion of Long-Term Debt	-	0.02	0.01	-	-	0.01	-	-
Accrued Liabilities	0.08	0.05	0.02	0.02	0.01	0.03	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	0.03	0.02	0.01	0.02	0.01	0.03	0.00	0.00
Total Current Liabilities	0.13	0.09	0.04	0.03	0.02	0.06	0.00	0.00
Non-Current Liabilities
Long-Term Debt	0.21	0.20	0.14	0.10	0.09	0.04	0.02	0.00
Other Non-Current Liabilities	0.35	0.34	0.31	0.12	0.01	0.00	0.00	0.00
Total Non-Current Liabilities	0.57	0.55	0.45	0.21	0.10	0.05	0.03	0.00
Total Liabilities	0.70	0.63	0.49	0.24	0.12	0.10	0.03	0.00
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-1.48	-1.26	-0.93	-0.73	-0.53	-0.39	-0.26	0.00
Additional Paid-in Capital	1.05	1.01	0.86	0.65	0.60	0.58	0.48	0.00
Shares Outstanding	0.07	0.07	0.06	0.04	0.03	-	-	-
Total Stockholders' Equity	-0.44	-0.25	-0.07	-0.07	0.07	0.19	0.23	0.00
Total Liabilities & Equity	0.26	0.38	0.41	0.16	0.19	0.30	0.26	0.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Phathom Pharmaceuticals Balance Sheet

How much debt does Phathom Pharmaceuticals have?

Phathom Pharmaceuticals had total debt of $209.74M as of Dec 31, 2025, against $129.97M in cash and short-term investments. Total debt was $221.19M a year earlier.

What are Phathom Pharmaceuticals's total assets?

Phathom Pharmaceuticals reported total assets of $259.15M as of Dec 31, 2025, down 31.5% from $378.32M a year earlier. Total liabilities were $697.32M.

What is Phathom Pharmaceuticals's shareholders' equity?

Phathom Pharmaceuticals's shareholders' equity was negative at −$438.17M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition